---
title: "Astrazeneca PLC Sponsored ADR Company (AZN.US) Q3 2021 Earnings Call"
description: "AstraZeneca Plc is a holding company engaged in the research, development and manufacture of drugs. The company produces and sells drugs for gastrointestinal, c"
locale: "en"
url: "https://longbridge.com/en/lives/3954"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Astrazeneca PLC Sponsored ADR Company (AZN.US) Q3 2021 Earnings Call

**Status**: Unknown
**Category**: Earnings Call

## Description

AstraZeneca Plc is a holding company engaged in the research, development and manufacture of drugs. The company produces and sells drugs for gastrointestinal, cardiovascular, neurology, respiratory and inflammatory diseases, oncology and infectious diseases. Their pipeline of products includes azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company sells products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem / Meronem, Carbocaine, Citanest, Diprivan, Marcaine / Sensorcaine. Astrazeneca PLC Sponsored ADR was established on June 17, 1992 and is headquartered in Cambridge, UK.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.